SUPPRESSA, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 3.297
SA - Sud America 3.070
NA - Nord America 1.830
EU - Europa 643
AF - Africa 429
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 9.273
Nazione #
BR - Brasile 2.402
US - Stati Uniti d'America 1.694
VN - Vietnam 1.361
SG - Singapore 1.022
CN - Cina 429
MA - Marocco 293
AR - Argentina 281
ID - Indonesia 160
EC - Ecuador 142
IT - Italia 122
DE - Germania 112
FI - Finlandia 76
CO - Colombia 75
RU - Federazione Russa 69
MX - Messico 68
BD - Bangladesh 63
ZA - Sudafrica 60
HK - Hong Kong 53
PY - Paraguay 53
FR - Francia 48
CL - Cile 39
GB - Regno Unito 36
IN - India 32
UY - Uruguay 32
NL - Olanda 31
AT - Austria 29
IQ - Iraq 29
PE - Perù 25
UA - Ucraina 24
PK - Pakistan 23
CA - Canada 22
VE - Venezuela 19
DO - Repubblica Dominicana 18
UZ - Uzbekistan 18
EG - Egitto 16
SE - Svezia 16
JP - Giappone 15
TN - Tunisia 14
AZ - Azerbaigian 13
DZ - Algeria 13
TR - Turchia 12
ES - Italia 10
AL - Albania 9
KE - Kenya 9
PL - Polonia 9
BG - Bulgaria 8
GA - Gabon 8
KW - Kuwait 8
HN - Honduras 7
PA - Panama 7
KZ - Kazakistan 6
LV - Lettonia 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
IE - Irlanda 4
LK - Sri Lanka 4
LT - Lituania 4
SN - Senegal 4
AM - Armenia 3
BE - Belgio 3
BH - Bahrain 3
BW - Botswana 3
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CY - Cipro 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
ME - Montenegro 1
ML - Mali 1
MT - Malta 1
NZ - Nuova Zelanda 1
Totale 9.267
Città #
Dallas 1.178
Ho Chi Minh City 525
Singapore 414
Hefei 283
Hanoi 274
Casablanca 266
São Paulo 197
The Dalles 83
Rio de Janeiro 80
Haiphong 68
Helsinki 67
Hong Kong 53
Ashburn 51
Curitiba 49
Beijing 44
Belo Horizonte 42
Quito 42
Brasília 40
Da Nang 39
Guayaquil 39
Porto Alegre 39
Hải Dương 35
Munich 35
Thái Bình 33
Campinas 31
Salvador 30
Biên Hòa 29
Los Angeles 29
Montevideo 26
Ninh Bình 25
Santo André 25
Buenos Aires 24
Frankfurt am Main 23
Johannesburg 23
Sorocaba 22
Can Tho 21
Guarulhos 21
Jakarta 21
Bắc Ninh 19
Fortaleza 18
Manaus 18
Recife 18
Ribeirão Preto 18
Boston 17
Goiânia 17
Nuremberg 17
Tashkent 17
Asunción 16
Baghdad 16
Osasco 16
Bogotá 15
Bắc Giang 15
Hortolândia 15
Lima 15
Mexico City 15
Sumaré 15
São José dos Campos 15
Thái Nguyên 15
Bauru 14
Cape Town 14
Piracicaba 14
Baku 13
Caxias do Sul 13
Ha Long 13
Joinville 13
Santiago 13
Contagem 12
Lấp Vò 12
Rio Claro 12
Canoas 11
Düsseldorf 11
Lahore 11
Matera 11
Montes Claros 11
New York 11
Quận Một 11
Santa Clara 11
Santo Domingo 11
São Bernardo do Campo 11
Tokyo 11
Vienna 11
Volta Redonda 11
Aracaju 10
Brooklyn 10
Cotia 10
Huế 10
Indaiatuba 10
Mauá 10
Montreal 10
Portsmouth 10
Stockholm 10
São Gonçalo 10
São José 10
Bragança Paulista 9
Cabo Frio 9
Hưng Yên 9
Itaquaquecetuba 9
Juiz de Fora 9
Lauterbourg 9
Limeira 9
Totale 5.112
Nome #
13C-methacetin breath test: A new tool to predict the presence of liver vascular malformations in patients with hereditary haemorragic teleangiectasia 546
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 96
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 84
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 64
A strange case from “the land of eagles” 59
"Si riconosce ciò che si conosce”: diagnosi forse tardiva di un caso raro di tumore neuroendocrino, il glucagonoma 57
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 57
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 56
Il fenotipo Hyper TG-Waist: un nuovo marker di rischio cardiovascolare nel paziente geriatrico 55
HHT: a rare disease with broad spectrum of clinical aspects 54
A new risk factor for cardiovascular disease in elderly: the HyperTg-waist phenotype 53
A case of brain vanishing tumor 53
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT). 51
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 51
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT) 51
What changed in the Italian internal medicine and geriatric wards during the lockdown 50
Another case of diagnostic delay brings about a serious brain abscess with complex clinical management 50
Efficacia dello screening genetico nella prevenzione del rischio tumorale e nella riduzione della mortalità in pazienti affetti da Sindrome di Lynch (HNPCC) 49
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy 48
Ultrasonographic analysis of HAVMS in a large cohort of hereditary hemorrhagic telangiectasia patients: definition of a new highly-accurate intrahepatic parameter 47
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 46
Large B cells non-Hodgkin lymphoma in a patient with chronic HBV infection 46
Screening con EGDS nella Teleangiectasia Emorragica Ereditaria (HHT) 46
The lower is better”: genetic pitfalls of a paradigmatic approach for dyslipidemia 46
The impact of cognitive level on disability in an aged population with Alzheimer disease 45
Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 44
Behavioural disorders and Alzheimer disease 44
Multi-source approach permits a better ascertainment and provides more reliable estimates of Hereditary Haemorrhagic Telangiectasia: a population-based study in Apulia, Italy 43
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 43
Pain and Frailty in Hospitalized Older Adults 43
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary haemorrhagic telangiectasia and atrial fibrillation 43
Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects 42
Thyroid nodules malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects 42
Relationship of serum free thyroxine (fT4) and thyroid stimulating hormone (TSH) with insulin resistance in an aged obese euthyroid population. 42
Malnutrizione: impatto sulla disabilità e mortalità in una popolazione anziana 41
Effects of double filtration plasmapheresis (DFPP) in nephrotic syndrome of hiv-associeted lupus-like glomerulonephritis 41
Liver involvement associated to hereditary haemmorrhagic telangiectasia in pediatric age 41
Cardiovascular risk in sarcoidosis: a prognostic stratification model based on subclinical atherosclerosis evaluation 41
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT). 41
Ultrasonographic Analysis of HAVMs in a large cohort of Hereditary Hemorrhagic Telangiectasia patients: definition of a new highly accurate intrahepatic parameter 41
A different negative T-wave interpretation 40
A spike at tumor onset earmarks low level instability in perpheral blood cells from Lynch Syndrome patients 40
Come superare le barriere all’implementazione delle strategie di prevenzione e cura della malattia cardiovascolare aterosclerotica mediante terapia ipolipemizzante 40
A chance for HoFH 40
Risk of pulmonary embolism and deep vein thrombosis in sarcoidosis: a systematic review and meta-analysis 40
Effects of VEGF on Phenotypic Severity in Children With Hereditary Hemorrhagic Telangiectasia 39
Orticaria e angioedema nei pazienti geriatrici 39
Manifestazioni cliniche in un'ampia coorte di pazienti pediatrici affetti da Teleangiectasia Emorragica Ereditaria 39
Quando la politica incontra la sanità e la scienza: l'approccio della Regione Puglia all'assistenza dei pazienti con malattie rare 39
Longitudinal study of natural history of arteriovenous malformations in evolutionary age of Hereditary haemorrhagic telangiectasia 39
Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 39
Shunts intraepatici e seminoma: insieme per caso? 38
Platelet to gamma-glutamyl transferase ratio: a novel easy-to-use tool to predict high lipoprotein(a) levels 38
Hepatic involvement and stiffness evaluation by elastography in hereditary hemorrhagic telangiectasia 38
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 38
Hepatic involvement and atrial fibrillation in geriatric patients with hereditary haemorrhagic telangiectasia 38
Sintomi clinici e prevalenza in una popolazione anziana sensibilizzata all'Anisakis 38
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 38
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 38
Braving the tide: the impact of the CoV-2 pandemic on quality of life, disease characteristics and trust in public health services in hereditary haemorrhagic telangiectasia and sarcoidosis patients 38
Asymptomatic microhematuria: An indication of hereditary hemorrhagic telangiectasia? 38
Hereditary haemorrhagic telangiectasia and oral anticoagulation: efficacy of percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation 37
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 37
Development of the “medical attitudes towards deprescribing questionnaire” (MATD-Q) 37
Coinvolgimento cerebrale in un campione esteso di pazienti italiani con Teleangiectasia Emorragica Ereditaria 37
La malattia celiaca non è più rara, ma a volte l'esordio è subdolo 37
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 36
Life expectancy in patients with heredetary haemorrhagic teleangectasia 36
Multifactorial thrombosis: a case report 36
IDENTIFICATION AND VALIDATION OF THE CHRONO MED DIET SCORE: A SURVEY IN 9200 SUBJECTS 36
Uso dell'Angio-RM dinamica nello studio delle alterazioni parenchimali epatiche di pazienti affetti da HHT: esperienza preliminare 36
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 36
A real-world follow-up experience of PCSK9i use in Bari Lipigen Center 36
Rapida ed efficiente caratterizzazione di mutazioni in pazienti con Teleangiectasia Emorragica Ereditaria mediante DHPLC 36
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 36
A peddler in a bizzarre body 36
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 35
Influence of genetics and metabolic factors on neutrophil-to-high density lipoprotein cholesterol ratio: a perspective observational study 35
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 35
Impact of electronic cigarettes (e-cigs) and heat-not-burn/heated tobacco products (HnB/HTP) on asthma and chronic obstructive pulmonary disease: a viewpoint of the Italian Society of Internal Medicine 35
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 35
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 35
Le malattie allergiche nell'anziano 35
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 35
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 34
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 34
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab 34
Anomalous skin pigmentation: unmasking a rare syndrome with relevance for the internist 34
Congenital analbuminemia in a patient affected by hypercolesterolemia 34
Capacità funzionale dei pazienti con malformazioni artero-venose polmonari diffuse: valutazione con test da sforzo al cicloergometro 34
Severe pulmonary involvement of smad4-mutated patients with juvenile polyposis/hereditary hemorrhagic telangiectasia combined syndrome 34
A rare case of intramuscular abscess in a patient with hereditary haemorrhagic telangiectasia 34
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 34
Real-world efficacy and safety of Inclisiran: a prospective cohort study 34
Patients affected by Hereditary Hemorragic Telangiectasia (rara disease) wait for the correct diagnosis more than 30 years 33
Diagnostic delay in rare diseases: the drama of a silent killer 33
Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form 33
Patient with Hereditary Haemorrhagic Telangiectasia wait >30 years on average to receive a correct diagnosis 33
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children 33
Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS) 33
Totale 4.669
Categoria #
all - tutte 70.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.643 0 0 0 367 74 274 91 86 260 92 270 129
2025/20267.932 169 1.302 2.254 3.870 286 51 0 0 0 0 0 0
Totale 9.575